Home > Insider Trading > Filing (0001708138-20-000105)

Filing Details

Accession Number:: 0001708138-20-000105
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-09-23 16:00:51
Reporting Period:: 2020-09-21

Accepted Time:: 2020-09-23 16:00:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc.	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1225474	L Joseph Goldstein	777 Old Saw Mill River Road Tarrytown NY 10591		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-09-21	3,784	$371.40	9,427	No	4	M	Direct
Common Stock	Acquisiton	2020-09-21	4,960	$380.95	14,387	No	4	M	Direct
Common Stock	Acquisiton	2020-09-21	7,830	$376.69	22,217	No	4	M	Direct
Common Stock	Disposition	2020-09-21	300	$543.19	21,917	No	4	S	Direct
Common Stock	Disposition	2020-09-21	700	$544.96	21,217	No	4	S	Direct
Common Stock	Disposition	2020-09-21	800	$546.01	20,417	No	4	S	Direct
Common Stock	Disposition	2020-09-21	1,356	$547.28	19,061	No	4	S	Direct
Common Stock	Disposition	2020-09-21	3,654	$548.13	15,407	No	4	S	Direct
Common Stock	Disposition	2020-09-21	2,600	$549.07	12,807	No	4	S	Direct
Common Stock	Disposition	2020-09-21	1,600	$550.11	11,207	No	4	S	Direct
Common Stock	Disposition	2020-09-21	1,501	$551.09	9,706	No	4	S	Direct
Common Stock	Disposition	2020-09-21	513	$552.01	9,193	No	4	S	Direct
Common Stock	Disposition	2020-09-21	1,101	$553.17	8,092	No	4	S	Direct
Common Stock	Disposition	2020-09-21	899	$554.82	7,193	No	4	S	Direct
Common Stock	Disposition	2020-09-21	1,530	$555.74	5,663	No	4	S	Direct
Common Stock	Disposition	2020-09-22	20	$552.36	5,643	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2020-09-21	3,784	$0.00	3,784	$371.40
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2020-09-21	7,830	$0.00	7,830	$376.69
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2020-09-21	4,960	$0.00	4,960	$380.95

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2029-01-02	No	4	M	Direct
0	2027-01-03	No	4	M	Direct
2,479	2028-01-02	No	4	M	Direct

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 300 shares of Company stock on September 21, 2020 at prices ranging from $542.66 to $543.48. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
Represents volume-weighted average price of sales of 700 shares of Company stock on September 21, 2020 at prices ranging from $544.49 to $545.37. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
Represents volume-weighted average price of sales of 800 shares of Company stock on September 21, 2020 at prices ranging from $545.56 to $546.53. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
Represents volume-weighted average price of sales of 1,356 shares of Company stock on September 21, 2020 at prices ranging from $546.57 to $547.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
Represents volume-weighted average price of sales of 3,654 shares of Company stock on September 21, 2020 at prices ranging from $547.61 to $548.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
Represents volume-weighted average price of sales of 2,600 shares of Company stock on September 21, 2020 at prices ranging from $548.62 to $549.60. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
Represents volume-weighted average price of sales of 1,600 shares of Company stock on September 21, 2020 at prices ranging from $549.62 to $550.52. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
Represents volume-weighted average price of sales of 1,501 shares of Company stock on September 21, 2020 at prices ranging from $550.64 to $551.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
Represents volume-weighted average price of sales of 513 shares of Company stock on September 21, 2020 at prices ranging from $551.69 to $552.51. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
Represents volume-weighted average price of sales of 1,101 shares of Company stock on September 21, 2020 at prices ranging from $552.69 to $553.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
Represents volume-weighted average price of sales of 899 shares of Company stock on September 21, 2020 at prices ranging from $554.32 to $555.22. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
Represents volume-weighted average price of sales of 1,530 shares of Company stock on September 21, 2020 at prices ranging from $555.51 to $556.04. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price.
On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.